FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
A. Agusti, M. Corradi, G. Cohuet, S. Vezzoli, D. Singh, J. Vestbo, P. Paggiaro, P. Jones, S. Petruzzelli, J. Wedzicha (Barcelona, Spain; Parma, Pisa, Italy; Manchester, London, United Kingdom)
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Agusti, M. Corradi, G. Cohuet, S. Vezzoli, D. Singh, J. Vestbo, P. Paggiaro, P. Jones, S. Petruzzelli, J. Wedzicha (Barcelona, Spain; Parma, Pisa, Italy; Manchester, London, United Kingdom). FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations. Eur Respir J 2013; 42: Suppl. 57, 762
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: